Injection drug use is an independent risk factor for iron deficiency and iron deficiency anemia among HIV-seropositive and HIV-seronegative women

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 2, 2005, Pages 198-201

  Dancheck, Barbara ^a,e   Tang, Alice M ^b   Thomas, Ann M ^b   Smit, Ellen ^c   Vlahov, David ^d   Semba, Richard D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d NEW YORK ACADEMY OF SCIENCES   (United States)

^e NONE   (United States)

Author keywords

Anemia; HIV; Injection drug use; Iron deficiency; Women

Indexed keywords

CD4 ANTIGEN; FERRITIN; HEMOGLOBIN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INJECTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; UNITED STATES;

ADULT; ANEMIA, IRON-DEFICIENCY; CASE-CONTROL STUDIES; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 25844440807     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000165909.12333.07     Document Type: Article

References (21)

1. Semba RD, Gray GE. The pathogenesis of anemia during human immunodeficiency viras infection. J Investig Med. 2001;49:225-239.
2. Semba RD. Iron deficiency anemia and the cycle of poverty among human immunodeficiency virus-infected women in the inner city. Clin Infect Dis. 2003;37(Suppl 2):S105-S111.
3. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001;131:568S-580S.
4. Haas JD, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001; 131(Suppl 2):676S-690S.
5. Semba RD, Shah N, Strathdee SA, et al. High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection. J Acquir Immune Defic Syndr. 2002;29:142-144.
6. Centers for Disease Control and Prevention (CDC). HIV/AIDS surveillance report: US HIV and AIDS cases reported through December 1999: year end edition. Atlanta: CDC. 2000;11:1-45.
7. Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973-976.
8. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. In: Hartsock P, Genser SG, eds. Longitudinal Studies of HIV Infection in Intravenous Drug Users: Methodological Issues in Natural History Research. National Institute on Drug Abuse Research Monograph 109. United States Department of Health and Human Services No. (ADM) 91-1786. Washington, DC: United States Government Printing Office; 1991:75-100.
9. Mast AE, Blinder MA, Gronowski AM, et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44:45-51.
10. Huberman M, Langholz B. Application of the missing-indicator method in matched case-control studies with incomplete data. Am J Epidemiol. 1999;150:1340-1345.
11. Spijkerman IJ, van Ameijden EJ, Mientjes GH, et al. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1148-1154.
12. Binswanger IA, Kral AH, Bluthenthal RN, et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579-581.
13. Kem WV, Engel A, Schieffer S, et al. Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis. Infect Immun. 1993;61:5413-5416.
14. Means RT, Jr. The anemia of infection. Ballieres Clin Hematol. 2000;13:151-162.
15. Murphy M, Perussia B, Trinchieri G. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp Hematol. 1988;16:131-138.
16. Erikson KM, Jones BC, Beard JL. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr. 2000;130:2831-2837.
17. Erikson KM, Jones BC, Hess EJ, et al. Iron deficiency decreases dopamine D1 and D2 receptors in the rat brain. Pharmacol Biochem Behav. 2001;69:409-418.
18. Koob GF, He HT, Creese I. The D 1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett. 1987;79:315-320.
19. Caine SB, Heinrichs SC, Coffin VL, et al. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 1995;692:47-56.
20. Galai N, Safaeian M, Vlahov D, et al. Longitudinal patterns of drug injection behavior in the ALIVE study cohort, 1988-2000: description and determinants. Am J Epidemiol. 2003;158:695-704.
21. Santen FJ, Sofsky J, Bilic N, et al. Mechanism of action of narcotics in the production of menstrual dysfunction in women. Fertil Steril. 1975;26:538-548.